Physician profile

Neal E Coleman

Pain Medicine (Anesthesiology) · Muncie, IN

NPI 1851349880

$38,220.19

in general payments reported to CMS, 2019-2025

47 companies · $639 in 2025

The $639 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

See the full distribution for Pain Medicine (Anesthesiology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,381.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Vertos Medical, INC. $12,832.30 2019-2021
Joimax, INC. $11,176.74 2019
Nevro Corp. $3,566.33 2019-2024 Senza
Mml US, INC. $1,979.31 2021-2025 Reactiv8
Medtronic USA, INC. $1,588.21 2019-2020
Surgentec $1,125.77 2022
Relievant Medsystems, INC. $922.16 2022
Choice Spine, LLC $756.56 2023 Tigershark C, Stratofuse, Blackhawk Cervical Spacer System
Boston Scientific Corporation $532.71 2019-2024 Wavewriter Alpha Prime 16
Arbor Pharmaceuticals, INC. $378.44 2020
Spinal Simplicity, LLC $370.54 2022-2024 Ha Minuteman G3-R
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $363.70 2019-2021
4web, INC. $265.21 2019-2020
Globus Medical, INC. $262.65 2025 Vyrsa V1, Senza
Medtronic, INC. $203.37 2021-2022
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Stryker Corporation $191.28 2019-2025 Mild Device Kit
Abbott Laboratories $153.87 2023-2025 Proclaim
Vertiflex, INC. $153.58 2019
Nalu Medical, INC. $134.03 2025 Nalu Neurostimulation System
Abbvie INC. $126.18 2021-2022
Pfizer INC. $114.10 2019-2021
Biohaven Pharmaceuticals, INC. $105.65 2020-2021
Astrazeneca Pharmaceuticals LP $95.79 2019-2021
Biodelivery Sciences International, INC. $91.04 2020-2021
Providence Medical Technology, INC. $76.33 2021
Spinal Elements, INC. $60.86 2019-2021
Amgen INC. $60.31 2021-2022
Redhill Biopharma INC. $54.45 2021-2022
Allergan, INC. $53.03 2020-2021
Lilly USA, LLC $47.13 2020-2021
Tersera Therapeutics LLC $45.88 2019
Stimwave Technologies Incorporated $34.77 2019
Si-Bone, INC. $33.81 2019-2021
Collegium Pharmaceutical, INC. $30.03 2022-2023 Xtampza
Almatica Pharma LLC $26.92 2021
Mdd US Operations, LLC $26.87 2020
Amarin Pharma, INC. $22.64 2021
Averitas Pharma INC. $21.68 2024 Qutenza
Novartis Pharmaceuticals Corporation $18.61 2020
Esperion Therapeutics, INC. $17.63 2021
Ultragenyx Pharmaceutical INC. $17.11 2021
Mylan Specialty L.P. $14.33 2021
Eisai INC. $14.33 2019
Pharmacyclics LLC, An Abbvie Company $14.14 2021
Pernix Therapeutics Holdings, INC. $13.66 2019
Virtus Pharmaceuticals LLC $13.55 2021
Kowa Pharmaceuticals America, INC. $12.60 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Neal E Coleman

$38,220.19

in general payments reported 2019-2025

Years
2019-2025
Top company
Vertos Medical, INC.
Context
The $639 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

https://glasscript.com/doctor/128884/neal-e-coleman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.